News Briefs

Study finds timing an issue in combination therapy for COVID-19 patients
February 13, 2021 - 7:30 pm

The SOLIDARITY and RECOVERY trials have shown the efficacy of single agents in Coronavirus disease (COVID-19) patients. Knowledge gaps remain regarding the timing of administration and combination treatment. We searched PubMed without language restriction for studies published from database inception until December 24, 2020, with the terms “SARS-CoV-2″ or ”COVID-19″ and “antiviral” and “lopinavir-ritonavir” and “ribavirin” and “umifenovir” and “interferon” and “steroids” and “antibiotics” and “Chinese medicine” and “intensive care unit” or “invasive mechanical ventilation” or “mortality” or “death” or “length of stay”. No relevant articles pertaining to different therapeutic options for COVID-19 was found.
Source: eClinicalMedicine

News Briefs

Trivia

What we can learn from the 1918 Flu Pandemic as the Omicron variant spreads
What we can learn from the 1918 Flu Pandemic as the Omicron variant spreads

Historically, most pandemics end within 2 to 3 years as the virus mutates into a less virulent pathogen and the population builds up immunity. This is what happened to the influenza strain behind the 1918 flu pandemic.

Twitter Handle

Copyright © 2022 I Daily Remedy